Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Partial knee implant study shows promising 5-Year results

NCT ID NCT03768128

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at the safety and performance of the Journey II UNI partial knee replacement in 154 people with knee arthritis. The main goal was to see how many implants were still working well 5 years after surgery. Researchers also tracked any side effects and checked X-rays to see how the implant and bone were doing over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

154 people

The number who actually took part.

Started

Aug 2018

Finished

May 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

JOURNEY™ II UNI Unicompartmental Knee System (UKS) in patients with non-inflammatory degenerative joint disease (NIDJD) of the knee requiring either medial or lateral compartment knee replacement.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects must meet all of the following criteria for inclusion in the study. 1. Unicompartmental, NIDJD, including OA, traumatic arthritis, or avascular necrosis. 2. Eighteen (18) years of age or older at the time of surgery. 3. Skeletally mature in the judgement of the PI. 4. Has met an acceptable preoperative medical clearance and is free of (or acceptably managed) cardiac, pulmonary, hematological, infection, or other conditions that would pose an excessive operative risk. 5. Willing and able to participate in required follow-up visits at the investigational site and to complete study procedures and questionnaires. 6. Consented to participate in the study by signing the EC-approved ICF. Exclusion Criteria: * Subjects meeting any of the following criteria must be excluded from participation in the study. 1. Correction of functional deformity. 2. Revision procedures where other treatments or devices have failed. 3. Treatment of fractures that are unmanageable using other techniques. 4. Inadequate bone stock to support the device which would make the procedure unjustifiable, including but not limited to severe osteopenia/osteoporosis or family history of severe osteoporosis/osteopenia. 5. Body Mass Index (BMI) \> 40. 6. Collateral ligament insufficiency. 7. Active infection, treated or untreated, systemic or at the site of the planned surgery or previous intra-articular infections. 8. Incomplete or deficient soft tissue surrounding the knee. 9. Conditions that may interfere with the UKA survival or outcome, including but not limited to Paget's disease, Charcot disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, renal insufficiency or neuromuscular disease. 10. Diagnosis of an immunosuppressive disorder. 11. Known allergy to study device or one or more of its components. 12. Pregnant or planning to become pregnant during the course of the study. 13. Subject, in the opinion of the PI, has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, mental retardation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Non-inflammatory degenerative joint disease (nidjd) of the knee are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Miejski Zabrze

    Zabrze, 41-803, Poland

  • Istituto Clinico Villa Aprica

    Como, 22100, Italy

  • OrthoIllinois, LTD

    Rockford, Illinois, 61114, United States

  • Poliambulanza Institute Hospital Foundation

    Brescia, 25124, Italy

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

  • Zeromski Hospital

    Krakow, 31-913, Poland